Fig. 6
From: Protective effect of Glechoma hederacea extract against gallstone formation in rodent models
Comparisons of Catalase (CAT) activities (a), Superoxide dismutase (SOD) inhibition rates (b) and Reduced glutathione (GSH) levels (c) in liver from different treatment groups for evaluating the anti-oxidative effect of Hitrechol®. n = 4 to 6 for each treatment group. Data presented in Mean ± SD, *p < 0.05 compared to VEH + ND group, ^p < 0.05 compared to H (QD) + ND group, #p < 0.05 compared to VEH + LGD group analyzed by one-way ANOVA followed by Tukey’s multiple comparisons test. VEH: Vehicle; ND: Normal diet; LGD: Lithogenic diet; H (QD): Hitrechol® once daily; H (TID): Hitrechol® three times daily. VEH + ND: Group 1; VEH + LGD: Group 2; H (QD) + ND: Group 3; H (QD) + LGD: Group 4; H (TID) + LGD: Group 5